Major stake in drug maker sold
- Share via
From Times Wire Services
Daiichi Sankyo Co. will buy a controlling stake in Ranbaxy Laboratories Ltd. for as much as $4.6 billion to enter the generic-drug market.
Daiichi Sankyo, Japan’s third-largest drug maker, will acquire more than 50.1% of Ranbaxy, India’s biggest pharmaceutical company, for a price 31% higher than Tuesday’s closing price, the Japanese company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
